Kira L Newman, MD, PhD
Manage Your Profile
About
Kira Newman MD, PhD is a Clinical Assistant Professor at the University of Michigan. She specializes in caring for patients with inflammatory bowel disease and is a member of the Inflammatory Bowel Disease Program at the University of Michigan. Dr. Newman earned her Bachelor Degree in History at Yale University. She earned her Medical Degree and completed a PhD in Epidemiology at Emory University. She completed her Internal Medicine Residency at the University of Washington and Gastroenterology Fellowship at the University of Michigan. Dr. Newman conducts mechanistic microbiome research on the role of the microbiome in Clostridioides difficile infection among people with inflammatory bowel disease, for which she was the recipient of a 2023 Career Development Award from the American College of Gastroenterology. Her clinical research focuses on health outcomes and healthcare equity for sexual and gender minority/LGBTQIA+ people with digestive diseases.
Qualifications
-
MDEmory University School of Medicine, Atlanta, United States
2010 - 2017
-
PhD, EpidemiologyEmory University, Atlanta, United States
2012 - 2015
-
BA, HistoryYale University, New Haven, United States
2006 - 2010
Center Memberships
-
Center MemberInstitute for Healthcare Policy and Innovation
Research Overview
CURRENT RESEARCH
C. difficile colonization in select populations
Advisors: Nobu Kamada, PhD, Peter Higgins, MD, PhD, MSc, Vincent Young, MD, PhD, Krishna Rao, MD, MS
Assessing for microbiome and host-related factors that contribute to colonization with C. difficile versus infection in healthy infants and adults with ulcerative colitis using murine models and enteric-mimicking bioreactors (2022-present)
Prevention of recurrent C. difficile infection through dietary modification
Advisor: Krishna Rao, MD, MS
Interventional pilot randomized control trial of a fiber-rich diet for prevention of recurrent C. difficile infection (CDI) in adults treated with antibiotics for non-severe CDI. (2025-present)
Health and wellbeing of sexual and gender minority people with IBD
Multiple projects involving collection of primary and secondary data to better understand healthcare disparities and patient experiences of sexual and gender minority people with inflammatory bowel disease (2022-present)
Recent Publications
-
Torkan SO, Condray C, Li P-H, Bhatt P, Asthana A, Elbeih A, Klucevek G, Manabat AJ, Reck EC, Higgins P, Bennett A, Boden EK, Newman KL, Chedid V, Field J. The American Journal of Gastroenterology, 2026 Oct 9; 121 (10S1): s375 - s375.Journal ArticleS1724 Similar IBD Monitoring but Higher Vaccination Uptake Among Sexual and Gender Minority Adults With Inflammatory Bowel Disease: A Multicenter Matched Cohort Study
DOI:10.14309/01.ajg.0001216148.88947.02 -
Goga J, Condray C, Newman KL. The American Journal of Gastroenterology, 2026 Oct 9; 121 (10S1): s405 - s405.Journal ArticleS1857 Food Insecurity Predicts Worse Health-Related Quality of Life in a Nationwide Cohort of US Adults With Inflammatory Bowel Disease
DOI:10.14309/01.ajg.0001216680.96549.9a -
Bell A, Arenberg B, Condray C, Galicia F, Ferrer D, Gilbert V, Bishu S, Berinstein J, Higgins P, Faye A, Newman KL. The American Journal of Gastroenterology, 2026 Oct 9; 121 (10S1): s416 - s416.Journal ArticleS1908 Safety and Effectiveness of Janus Kinase Inhibitors Versus Infliximab in Older Adults With Inflammatory Bowel Disease
DOI:10.14309/01.ajg.0001216884.83159.e3 -
Bhatt P, Reck EC, Elbeih A, Condray C, Li P-H, Asthana A, Klucevek G, Manabat AJ, Torkan SO, Higgins P, Bennett A, Field J, Boden EK, Newman KL, Chedid V. The American Journal of Gastroenterology, 2026 Oct 9; 121 (10S1): s428 - s428.Journal ArticleS1964 Gender-Affirming Hormone Therapy Is Linked to Fewer IBD Hospitalizations and ED Visits in Transgender and Gender Diverse Patients: A Multicenter Cohort Study
DOI:10.14309/01.ajg.0001217108.78872.3a -
Condray C, Li P-H, Torkan SO, Bhatt P, Asthana A, Elbeih A, Klucevek G, Manabat AJ, Reck EC, Higgins P, Chedid V, Field J, Bennett A, Boden EK, Newman KL. The American Journal of Gastroenterology, 2026 Oct 9; 121 (10S1): s431 - s431.Journal ArticleS1978 Sexual Minority Adults With Inflammatory Bowel Disease Have Lower Rates of Advanced Therapy Access Than Non-Sexual Minority Adults: Results of a Matched Multi-Center Cohort Study
DOI:10.14309/01.ajg.0001217164.52551.c7 -
Chedid V, Newman KL, Pulliam CD, Aiello A, Jimenez JM, Chadha CA, Carter JD, McLafferty M, Atcheson S, Molloy L, Simone L, Nelson M. The American Journal of Gastroenterology, 2026 Oct 9; 121 (10S1): s431 - s431.Journal ArticleS1979 Bolstering Patient and Provider Confidence in Addressing Unique Aspects of Inflammatory Bowel Disease (IBD) Care as It Relates to Gender, Sexual Orientation, and Sexual Practices for LGBTQ+ Individuals
DOI:10.14309/01.ajg.0001217168.23198.09 -
Li P-H, Condray C, Torkan SO, Bhatt P, Elbeih A, Klucevek G, Manabat AJ, Reck EC, Asthana A, Vinsel P, Chedid V, Field J, Higgins P, Bennett A, Newman KL, Boden EK. The American Journal of Gastroenterology, 2026 Oct 9; 121 (10S1): s451 - s451.Journal ArticleS2071 Reduced Advanced Therapy Use and Increased Emergent Surgery Among Transgender and Gender Diverse Adults With Inflammatory Bowel Disease: A Multicenter Cohort Study
DOI:10.14309/01.ajg.0001217536.18980.50 -
Newman KL, James G, Standke AK, Kao JY, Higgins P, Rao K, Young VB, Moon J, Kamada N. The American Journal of Gastroenterology, 2026 Oct 9; 121 (10S1): s481 - s481.Journal ArticleS2205 Inulin Restores Colonization Resistance Against C. difficile of Ulcerative Colitis Patient Microbiomes In Vitro
DOI:10.14309/01.ajg.0001218072.98260.7a
Featured News & Stories
As probiotic use surges, microbiome-supportive food consumption stagnates